Description
CJC-1295 Without DAC is a synthetic peptide analog of growth hormone releasing hormone (GHRH) used in research and formulation settings to study peptide signaling, pituitary response, and pulsatile GH-related pathway activity. It is also commonly referred to as Modified GRF (1-29) or GHRH (1-29)-NH2. Supplier references distinguish it from CJC-1295 with DAC by noting that the without-DAC version lacks the Drug Affinity Complex, resulting in a shorter-acting research profile.
In laboratory literature and supplier documentation, this compound is described as a synthetic GHRH peptide derivative used to investigate growth hormone secretion dynamics and related receptor signaling. Cayman specifically notes activity in primary rat anterior pituitary cells and in rat blood in experimental contexts, while emphasizing that the compound is for laboratory research use only.
ATTENTION: All Unique ChemX products featured here are intended exclusively for research and development purposes. They are not designed for any form of human or animal consumption. These products have not undergone evaluation by the U.S. Food and Drug Administration.
